Modafinil is a novel wake-promoting agent approved for the treatment of excessive sleepiness associated with narcolepsy that holds significant promise as an alternative treatment to traditional psychostimulants for excessive fatigue associated with medical and psychiatric disorders and as augmentation medication for treatment-resistant depression.

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737175.2.4.449DOI Listing

Publication Analysis

Top Keywords

modafinil future
4
future modafinil
4
modafinil novel
4
novel wake-promoting
4
wake-promoting agent
4
agent approved
4
approved treatment
4
treatment excessive
4
excessive sleepiness
4
sleepiness associated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!